↓ Skip to main content
What is this page? Embed badge

First-line treatment for patients with advanced non-small cell lung carcinoma and high PD-L1 expression: pembrolizumab or pembrolizumab plus chemotherapy

Overview of attention for article published in Journal for Immunotherapy of Cancer, May 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
17 X users

Citations

dimensions_citation
63 Dimensions

Readers on

mendeley
70 Mendeley
Summary X Dimensions citations
So far, Dimensions has found 63 publications that cite this research output.

63

The most recent citing publications are shown below. View all 63 publications that cite this research output on Dimensions.

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.

This page is provided by Altmetric.